Comparative and functional genomics of the Mycobacterium tuberculosis complex

Microbiology

Volumn 148, Issue 10, 2002, Pages 2919-2928

  Cole, Stewart T ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

BCG vaccine; Bioinformatics; Evolution; Pathogenesis; PE and PPE families

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; GLUTAMINE; HYDRAZIDE DERIVATIVE; LIVE VACCINE; NICOTINIC ACID; PROLINE; PYRAZINAMIDE; THIOPHEN 2 CARBOXYLIC HYDRAZIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; CONTROLLED STUDY; GENE DELETION; GENE IDENTIFICATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOMICS; HUMAN; IMMUNOGENICITY; MICROBIAL ATTENUATION; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS; VIRULENCE;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; PROKARYOTA;

EID: 0036775772     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-148-10-2919     Document Type: Review

References (74)

1. Anon (1996). Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 348, 17-24.
2. Aoyama, Y., Horiuchi, T., Gotoh, O., Noshiro, M. & Yoshida, Y. (1998). CYP51-like gene of Mycobacterium tuberculosis actually encodes a P450 similar to eukaryotic CYP51. J Biochem 124, 694-696.
3. Bange, W. R., Collins, F. M. & Jacobs, W. R., Jr (1999). Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosis. Tuber Lung Dis 79, 171-180.
4. Banu, S., Honoré, N., Saint-Joanis, B., Philpott, D., Prévost, M.-C. & Cole, S. T. (2002). Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 44, 9-19.
5. Bardarov, S., Kriakov, J., Carriere, C., Yu, S., Vaamonde, C., McAdam, R., Bloom, B. R., Hatfull, G. R. & Jacobs, W. R., Jr (1997). Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 94, 10961-10966.
6. Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S. & Small, P. M. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarrays. Science 284, 1520-1523.
7. Berthet, F. X., Rasmussen, P. B., Rosenkrandt, I., Andersen, P. & Gicquel, B. (1998). A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144, 3195-3203.
8. Betts, J. C., Dodson, P., Quan, S., Lewis, A. P., Thomas, P. J., Duncan, K. & McAdam, R. A. (2000). Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551. Microbiology 146, 3205-3216.
9. Bloom, B. R. & Fine, P. E. M. (1994). The BCG experience: implications for future vaccines against tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control, pp. 531-557. Edited by B. R. Bloom. Washington, DC: American Society for Microbiology.
10. Brennan, M. J. & Delogu, G. (2002). The PE multigene family: a molecular mantra for mycobacteria. Trends Microbiol 10, 246-249.
11. Brennan, M. J., Delogu, G., Chen, Y., Bardarov, S., Kriakov, J., Alavi, M. & Jacobs, W. R., Jr (2001). Evidence that mycobacterial PERS proteins are cell surface constituents that influence interactions with other cells. Infect Immun 69, 7326-7333.
12. Brodin, P., Eiglmeier, K., Marmiesse, M., Billault, A., Garnier, T., Niemann, S., Cole, S. T. & Brosch, R. (2002). Bacterial Artificial Chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. Infect Immun 70 (in press).
13. Brosch, R., Gordon, S. V., Billault, A., Garnier, T., Eiglmeier, K., Soravito, C., Barrell, B. G. & Cole, S. T. (1998). Use of a Mycobacterium tuberculosis H37Rv Bacterial Artificial Chromosome (BAC) library for genome mapping, sequencing and comparative genomics. Infect Immun 66, 2221-2229.
14. Brosch, R., Philipp, W., Stavropolous, E., Colston, M. J., Cole, S. T. & Gordon, S. V. (1999). Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra. Infect Immun 67, 5768-5774.
15. Brosch, R., Gordon, S. V., Eiglmeier, K., Garnier, T., Tekaia, F., Yeramian, E. & Cole, S. T. (2000). Genomics, biology, and evolution of the Mycobacterium tuberculosis complex. In Molecular Genetics of Mycobacteria, pp. 19-36. Edited by G. F. Hatfull & W. R. Jacobs, Jr. Washington, DC: American Society for Microbiology.
16. Brosch, R., Gordon, S. V., Marmiesse, M. & 12 other authors (2002). A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99, 3684-3689.
17. Calmette, A. (1927). La vaccination préventive contre la tuberculose. Paris: Masson et cie.
18. Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B. & Guilhot, C. (1999). Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34, 257-267.
19. Camus, J.-C., Pryor, M. J., Médigue, C. & Cole, S. T. (2002). Reannotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148, 2967-2973.
20. Cole, S. T. (1999). Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Lett 452, 7-10.
21. Cole, S. T. (2002). Comparative mycobacterial genomics as a tool for drug target and antigen discovery. Eur Respir J (in press).
22. Cole, S. T. & Barrell, B. G. (1998). Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found Symp 217, 160-172.
23. Cole, S. T., Brosch, R., Parkhill, J. & 39 other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
24. Cole, S. T., Eiglmeier, K., Parkhill, J. & 42 other authors (2001). Massive gene decay in the leprosy bacillus. Nature 409, 1007-1011.
25. Daffé M. & Draper, P. (1998). The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39, 131-203.
26. Delogu, G. & Brennan, M. J. (2001). Comparative immune response to PE and PERS antigens of Mycobacterium tuberculosis. Infect Immun 69, 5606-5611.
27. Dye, C., Sheele, S., Dolin, P., Pathania, V. & Raviglione, M. C. (1999). Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA (J Am Med Assoc) 282, 677-686.
28. Dye, C., Espinal, M. A., Watt, C. J., Mbiaga, C. & Williams, B. G. (2002). Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 185, 1197-1202.
29. Eiglmeier, K., Parkhill, J., Honoré, N. & 12 other authors (2001). The decaying genome of Mycobacterium leprae. Lepr Rev 72, 387-398.
30. Espinal, M. A., Dye, C., Raviglione, M. & Kochi, A. (1999). Rational 'DOTS plus' for the control of MDR-TB. Int J Tuberc Lung Dis 3, 561-563.
31. Espitia, C., Laclette, J. P., Mondragon-Palomino, M. & 7 other authors (1999). The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology 145, 3487-3495.
32. Fine, P. E. M. (1995). Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345.
33. Gordon, S. V., Brosch, R., Billault, A., Garnier, T., Eiglmeier, K. & Cole, S. T. (1999a). Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32, 643-656.
34. Gordon, S. V., Heym, B., Parkhill, J., Barrell, B. & Cole, S. T. (1999b). New insertion sequences and a novel repeated sequence in the genome of Mycobacterium tuberculosis H37Rv. Microbiology 145, 881-892.
35. Gordon, S. V., Eiglmeier, K., Garnier, T., Brosch, R., Parkhill, J., Barrell, B., Cole, S. T. & Hewinson, R. G. (2001a). Genomics of Mycobacterium bovis. Tuberculosis (Edinb) 81, 157-163.
36. Gordon, S. V., Eiglmeier, K., Garnier, T., Parkhill, J., Barrell, B., Cole, S. T. & Hewinson, R. G. (2001b). Genomics of Mycobacterium bovis. Tuber Lung Dis 6, 157-163.
37. Haas, F. & Haas, S. S. (1996). The origins of Mycobacterium tuberculosis and the notion of its contagiousness. In Tuberculosis, pp. 4-19. Edited by W. N. Rom & S. Garay. Boston: Little, Brown and Company.
38. Harboe, M., Oettinger, T., Wiker, H. G., Rosenkrands, I. & Andersen, P. (1996). Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64, 16-22.
39. Hart, P. D. & Sutherland, I. (1977). BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 2, 293-295.
40. Hermans, P. W. M., van Soolingen, D. & van Embden, J. D. A. (1992). Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae. J Bacteriol 174, 4157-4165.
41. Hinds, J., Mahenthiralingam, E., Kempsell, K. E., Duncan, K., Stokes, R. W., Parish, T. & Stoker, N. G. (1999). Enhanced gene replacement in mycobacteria. Microbiology 145, 519-527.
42. Ho, T. B. L., Robertson, B. D., Taylor, G. M., Shaw, R. J. & Young, D. B. (2001). Comparison of Mycobacterium tuberculosis genomes reveals frequent deletions in a 20 kb variable region in clinical isolates. Yeast 17, 272-282.
43. Hondalus, M. K., Bardarov, S., Russell, R., Chan, J., Jacobs, W. R., Jr & Bloom, B. R. (2000). Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 68, 2888-2898.
44. Imaeda, T. (1985). Deoxyribonucleic acid relatedness among selected strains of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium micoti and Mycobacterium africanum. Int J Syst Bacteriol 35, 147-150.
45. Jackson, M., Phalen, S. W., Lagranderie, M., Ensergueix, D., Chavarot, P., Marchal, G., McMurray, D. N., Gicquel, B. & Guilhot, C. (1999). Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 67, 2867-2873.
46. Jacobs, W. R., Jr, Kalpana, G. V., Cirillo, J. D., Pascopella, L., Snapper, S. B., Udani, R. A., Jones, W., Barletta, R. G. & Bloom, B. R. (1991). Genetic systems for mycobacteria. Methods Enzymol 204, 537-555.
47. Kapur, V., Whittam, T. S. & Musser, J. (1994). Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis 170, 1348-1349.
48. Kato-Maeda, M., Rhee, J. T., Gingeras, T. R., Salamon, H., Drenkow, J., Smittipat, N. & Small, P. M. (2001). Comparing genomes within the species Mycobacterium tuberculosis. Genome Res 11, 547-554.
49. Koch, R. (1882). Die Aetiogie der Tuberculose. Berl Klin Wochenschr 19, 221-230.
50. Lillebaek, T., Dirksen, A., Baess, I., Strunge, B., Thomsen, V. O. & Andersen, A. B. (2002). Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis 185, 401-404.
51. Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C. & Stover, C. K. (1996). Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178, 1274-1282.
52. Munro, A. W. & Lindsay, J. G. (1996). Bacterial cytochromes P450. Mol Microbiol 20, 1115-1125.
53. Murray, J. R. (1990). Cursed duet: HIV-infection and tuberculosis. Respiration 57, 210-220.
54. Parish, T. & Stoker, N. G. (2000). Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146, 1969-1975.
55. Pelicic, V., Jackson, M., Reyrat, J. M., Jacobs, W. R., Jr, Gicquel, B. & Guilhot, C. (1997). Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 94, 10955-10960.
56. Philipp, W. J., Poulet, S., Eiglmeier, K. & 7 other authors (1996). An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A 93, 3132-3137.
57. Poulet, S. & Cole, S. T. (1995a). Characterisation of the polymorphic GC-rich repetitive sequence (PGRS) present in Mycobacterium tuberculosis. Arch Microbiol 163, 87-95.
58. Poulet, S. & Cole, S. T. (1995b). Repeated DNA sequences in mycobacteria. Arch Microbiol 163, 79-86.
59. Ramakrishnan, L., Federspiel, N. A. & Falkow, S. (2000). Granuloma-specific expression of mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288, 1436-1439.
60. Salamon, H., Kato-Maeda, M., Small, P. M., Drenkow, J. & Gingeras, T. R. (2000). Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. Genome Res 10, 2044-2054.
61. Salo, W. L., Aufderheide, A. C., Buikstra, J. & Holcomb, T. A. (1994). Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc Natl Acad Sci U S A 91, 2091-2094.
62. Sampson, S. L., Lukey, P., Warren, R. M., van Heiden, P. D., Richardson, M. & Everett, M. J. (2001). Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. Tuberculosis (Edinb) 81, 305-317.
63. Scorpio, A. & Zhang, Y. (1996). Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2, 662-667.
64. Singh, K. K., Zhang, X., Patibandla, A. S., Chien, P., Jr & Laal, S. (2001). Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences. Infect Immun 69, 4185-4191.
65. Sorensen, A. L., Nagai, S., Houen, G., Andersen, P. & Andersen, A. B. (1995). Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63, 1710-1717.
66. Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S. & Musser, J. M. (1997). Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 94, 9869-9874.
67. Steenken, W., Jr & Gardner, L. U. (1946). History of H37 strain of tubercle bacillus. Am Rev Tuberc, 54, 62-66.
68. Stover, C. K., De la Cruz, V. F., Fuerst, T. R. & 11 other authors (1991). New use of BCG for recombinant vaccines. Nature 351, 456-460.
69. Stover, C. K., de la Cruz, V. F., Bansal, G. P., Hanson, M. S., Fuerst, T. R., Jacobs, W. R., Jr & Bloom, B. R. (1992). Use of recombinant BCG as a vaccine delivery vehicle. Adv Exp Med Biol 327, 175-182.
70. Tekaia, F., Gordon, S. V., Garnier, T., Brosch, R., Barrell, B. G. & Cole, S. T. (1999). Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber Lung Dis 79, 329-342.
71. van Soolingen, D., de Haas, P. E. W., Hermans, P. W. M., Groenen, P. M. A. & van Embden, J. D. A. (1993). Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 31, 1987-1995.
72. Wells, A. Q. (1937). Tuberculosis in wild voles. Lancet 232, 1221.
73. Wheeler, P. R. & Ratledge, C. (1994). Metabolism of Mycobacterium tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control, pp. 353-385. Edited by B. R. Bloom. Washington, DC: American Society for Microbiology.
74. Zhang, Y. & Young, D. B. (1994). Strain variation in the katG region of Mycobacterium tuberculosis. Mol Microbiol 14, 301-308.